Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/14/1990 | EP0357857A1 Human serum albumin crystals and method of preparation |
03/14/1990 | EP0357856A1 DNA coding for human ventricular myosin light chain 2 |
03/14/1990 | EP0357804A1 Compositions containing modified erythropoietin |
03/14/1990 | EP0357773A1 Process for preparing liposomes |
03/14/1990 | EP0357730A1 Blocking, isolating and purifying calcium channels |
03/14/1990 | EP0357674A1 Extraction of granulocyte macrophage colony stimulating factor from bacteria |
03/14/1990 | EP0357645A1 Improved process for recovering microbially produced interleukin-2. |
03/14/1990 | EP0357642A1 Vaccine against brucella abortus |
03/14/1990 | EP0357638A1 Regulation of amino acid synthesis using leu3 |
03/14/1990 | EP0357637A1 General cancer-associated scm-recognition factor, preparation and method of use. |
03/14/1990 | EP0357622A1 Substituted complex-forming substances, complexes and complex salts, process for manufacture thereof and pharmaceutical agents which contain them |
03/14/1990 | EP0200653B1 Hybrid cells producing a hepatitis b virus antigen obtained from hepatocytes and established monkey cells, process for the obtention of these hybrid cells and use thereof in the production of this antigen |
03/13/1990 | US4908434 Treating human lymphocytes to obtain medium containing interleukin-2, recovering protein components, subjecting protein components to anion exchange chromatography, gel filtration chromatography, hydrophobic chromatography |
03/13/1990 | US4908433 Uses of interleukin-2 |
03/13/1990 | US4908432 Novel polypeptide having gamma-interferon activity |
03/13/1990 | US4908405 Graft copolymers of crosslinked polymers and polyoxyethylene, processes for their production, and their usage |
03/13/1990 | US4908404 Water soluble high molecular weight cationic graft polymer |
03/13/1990 | US4908352 Urotensin peptides |
03/13/1990 | US4908351 Pseudoaglycon |
03/13/1990 | CA1266628A1 Manufacture and expression of structural genes |
03/13/1990 | CA1266627A1 Use of a recombinant dna comprising a nucleotide sequence coding for a given polypeptide under the control of an adenovirus promoter |
03/13/1990 | CA1266613A1 Inductive collagen based bone repair preparations |
03/08/1990 | WO1990002207A1 Cloned nephritis antigen |
03/08/1990 | WO1990002206A1 Detection of non-a, non-b hepatitis |
03/08/1990 | WO1990002198A1 O-glycosylated igf-1 |
03/08/1990 | WO1990002196A1 Method for producing native hiv gp160 |
03/08/1990 | WO1990002191A1 Recombinant fowlpox virus |
03/08/1990 | WO1990002190A1 Vaccine |
03/08/1990 | WO1990002189A1 Expression cassette for plants |
03/08/1990 | WO1990002187A1 Recombinant fusion proteins for altering hormone secretion |
03/08/1990 | WO1990002186A1 Production of bluetongue virus non-structural proteins using a baculovirus expression vector |
03/08/1990 | WO1990002185A1 Cocumber mosaic virus coat protein gene |
03/08/1990 | WO1990002184A1 Potyvirus coat protein genes and plants transformed therewith |
03/08/1990 | WO1990002183A1 Production of a novel lymphokine exhibiting differentiation inhibitory activity |
03/08/1990 | WO1990002182A1 Novel somatotropins |
03/08/1990 | WO1990002181A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
03/08/1990 | WO1990002180A1 A FULL LENGTH cDNA ENCODING A HUMAN LAMININ BINDING PROTEIN |
03/08/1990 | WO1990002178A1 A method of preparing an active human neutrophil chemotactic factor polypeptide |
03/08/1990 | WO1990002177A1 Parathion hydrolase analogs and methods for production and purification |
03/08/1990 | WO1990002176A1 Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders |
03/08/1990 | WO1990002172A1 Plant elongation factor, promoters, coding sequences and uses |
03/08/1990 | WO1990002140A1 Method for purifying teneicine |
03/08/1990 | WO1990002139A1 Synthetic, anti-complement protein and the gene encoding same |
03/08/1990 | WO1990002137A1 Renin inhibitory peptides containing suleptanic acid or derivatives thereof |
03/08/1990 | WO1990002136A1 Protein derivatives and a process for their preparation |
03/08/1990 | WO1990002135A1 Protein derivatives and a process for their preparation |
03/08/1990 | WO1990002132A1 Milk constituents, process for producing them and agents containing them |
03/08/1990 | WO1990001946A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus |
03/08/1990 | WO1990001944A1 Legionellosis vaccines and methods for their production |
03/08/1990 | WO1990001943A2 Treatment of myeloid leukemias by inducing terminal differentiation with interleukin-6 |
03/08/1990 | WO1990001941A1 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
03/08/1990 | WO1990001940A1 Atrial natriuretic peptide clearance inhibitors |
03/08/1990 | WO1990001900A1 Carrier system and method for enhancement of magnetic resonance imaging |
03/08/1990 | WO1990001870A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids |
03/08/1990 | WO1990000179A3 Novel proteins, dna coding for said proteins, and their use |
03/07/1990 | EP0357585A2 Preparation active against infections by Pseudomonas aeruginosa, and preparation containing immunoglobulin-G active against Pseudomonas aeruginosa |
03/07/1990 | EP0357510A1 Cyclopeptide derivatives for use as selective inhibitors against active serine protease |
03/07/1990 | EP0357391A2 Excretion of heterologous proteins from E. Coli |
03/07/1990 | EP0357332A2 Renin inhibitors useful for the treatment of aids by inhibition of HIV protease |
03/07/1990 | EP0357208A1 Salmonella transformant capable of expression of heterologous genes and useful as a recombinant vaccine |
03/07/1990 | EP0357119A2 A method for enhancing production of secondary metabolites using clustered biosynthetic genes |
03/07/1990 | EP0357067A2 Recombinant natural killer cell activator |
03/07/1990 | EP0357024A2 Dipoprotein I (OMPI) from Pseudomonas aeruginosa |
03/07/1990 | EP0356894A1 A novel glycopeptide antibiotic Decaplanin, a process for its production and its use as medicament |
03/07/1990 | EP0356836A2 Thrombin-binding substance and process for preparing the same |
03/07/1990 | EP0356796A2 Aminomethyl peptides, production process and their use as medicaments |
03/07/1990 | EP0356695A1 In vitro synthesis of an infectious RNA |
03/07/1990 | EP0356595A1 Novel peptidase inhibitors |
03/07/1990 | EP0356481A1 Purified hemoglobin solutions and method for making same. |
03/07/1990 | EP0356450A1 Diagnostics and vaccines for mycobacteria in public health, medical and veterinary practice |
03/07/1990 | CN1040222A Process for preparing de-b30-insulins and de-b30-insulins derivs. |
03/07/1990 | CN1040205A Cytotoxic drug conjugates |
03/07/1990 | CN1040204A Cytotoxic drug conjugates |
03/06/1990 | US4906742 Encoding antigens of M. Leprae |
03/06/1990 | US4906734 Human conglutinin |
03/06/1990 | US4906570 Polymers based on polyvinylene carbonate and/or polyhydroxymethylene as carriers for biologically active substances |
03/06/1990 | US4906564 Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
03/06/1990 | US4906468 Insulin activity messengers, their antibodies, and thereof |
03/06/1990 | US4906452 Trichothecene conjugates and methods of use |
03/01/1990 | DE3829552A1 Milchbestandteile, verfahren zu ihrer herstellung und mittel, die diese bestandteile enthalten Dairy ingredients, processes for their preparation and products containing these ingredients |
03/01/1990 | DE3828940A1 Cross-flow filtration unit for treating media containing cells, in particular blood |
02/28/1990 | EP0356409A2 A method for the production and isolation of a fusion protein in eukaryotic cells |
02/28/1990 | EP0356397A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
02/28/1990 | EP0356395A2 Flanking peptides and process for their preparation |
02/28/1990 | EP0356335A1 Signal peptide and DNA sequences coding thereof |
02/28/1990 | EP0356223A2 HIV protease inhibitors useful for the treatment of aids |
02/28/1990 | EP0356180A1 Treatment of myeloid leukemias by inducing terminal differentiation with interleukin-6 |
02/28/1990 | EP0356124A2 Atrial natriuretic peptide clearance inhibitors |
02/28/1990 | EP0356107A2 Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
02/28/1990 | EP0356007A2 Antigenic determinants |
02/28/1990 | EP0355882A1 Method for the preparation of fibronectine from blood plasma, with the help of affinity chromatography and the column material to be used with it |
02/28/1990 | EP0355860A1 A bifunctional metal chelating agent and a precursor compound |
02/28/1990 | EP0355811A2 Thrombus control agent |
02/28/1990 | EP0355794A2 Neuropeptide Y antagonists |
02/28/1990 | EP0355793A2 Neuropeptide Y agonists and partial agonists |
02/28/1990 | EP0355737A2 Expression of functional homologous and heterologous proteins on the outer membrane of E.coli and other gram-negative bacteria |
02/28/1990 | EP0355720A1 Process for the preparation of motilin-like polypeptide and expression thereof |
02/28/1990 | EP0355625A1 Gene regulation cassettes, exüressopm vectors containing the same and microorganisms transformed with the same |
02/28/1990 | EP0355460A2 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization |
02/28/1990 | EP0355331A2 Poly(aminoalkyl)aminocarbonyl aminoacyl aminodiol amino acid derivatives as anti-hypertensive agents |